2024.11.29
YouTube
第2回つぼラボ学会が開かれました！
[Interview] Dr. Reiko Arita, Ophthalmologist, Discusses the Potential of “TLM-001,” a Candidate Drug for Meibomian Gland Dysfunction Being Developed by the Tsubota Lab
【対談】眼科医有田玲子先生に伺う、坪田ラボが挑むマイボーム腺機能不全治療薬候補「TLM-001」の可能性
Financial Results Briefing for the First Quarter of the Fiscal Year Ending March 2027
2027年3月期第1四半期決算説明